Mesothelioma Surgery Recovery - Revision history

MesotheliomaSupport: Add Abdominal Cancers Alliance peritoneal mesothelioma resources citation in CRS-HIPEC recovery section (HANNA outreach pipeline event 5902, CLEO PASS 5905)

2026-05-10T01:24:48Z

Add Abdominal Cancers Alliance peritoneal mesothelioma resources citation in CRS-HIPEC recovery section (HANNA outreach pipeline event 5902, CLEO PASS 5905)

← Older revision		Revision as of 01:24, 10 May 2026
Line 128:		Line 128:

	Hospital stays after CRS-HIPEC range from 8 to 22 days, reflecting the variability in surgical extent and individual recovery rates. Total recovery takes approximately 3 months, with the initial home recovery phase lasting 2 to 3 weeks. In the largest reported cohort of 195 patients treated with CRS and HIPEC, median survival was 3.21 years, with patients who completed the full treatment protocol showing significantly improved outcomes compared to those who received incomplete treatment.<ref name="asco_hipec_outcomes" /><ref name="baratti_2013" /><ref name="italian_crshipec" />		Hospital stays after CRS-HIPEC range from 8 to 22 days, reflecting the variability in surgical extent and individual recovery rates. Total recovery takes approximately 3 months, with the initial home recovery phase lasting 2 to 3 weeks. In the largest reported cohort of 195 patients treated with CRS and HIPEC, median survival was 3.21 years, with patients who completed the full treatment protocol showing significantly improved outcomes compared to those who received incomplete treatment.<ref name="asco_hipec_outcomes" /><ref name="baratti_2013" /><ref name="italian_crshipec" />

			The [https://www.abdominalcancers.org/peritoneal-mesothelioma Abdominal Cancers Alliance] provides patient and caregiver resources specifically for peritoneal mesothelioma, including education on cytoreductive surgery (CRS) and HIPEC, post-surgical recovery, and connections to specialized surgical oncologists experienced in CRS-HIPEC procedures.<ref name="abdominal_cancers_alliance">[https://www.abdominalcancers.org/peritoneal-mesothelioma Peritoneal Mesothelioma Resources], Abdominal Cancers Alliance</ref>

	=== Abdominal Recovery and Dietary Progression ===		=== Abdominal Recovery and Dietary Progression ===

MesotheliomaSupport: RON: Add OG/Twitter meta — type=Article, image=logo.png, twitter_card=summary_large_image

2026-04-25T14:17:39Z

RON: Add OG/Twitter meta — type=Article, image=logo.png, twitter_card=summary_large_image

← Older revision		Revision as of 14:17, 25 April 2026
Line 5:		Line 5:
	\|author=David Foster, Patient Advocate, Danziger & De Llano		\|author=David Foster, Patient Advocate, Danziger & De Llano
	\|published_time=2026-02-19		\|published_time=2026-02-19
	}}		\|type=Article
			\|image=logo.png
			\|twitter_card=summary_large_image}}
	{\| class="infobox" style="width:300px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"		{\| class="infobox" style="width:300px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"
	\|-		\|-

MesotheliomaSupport: Add 15 primary peer-reviewed citations (Sugarbaker 2004, Taioli 2015 meta-analysis, Baratti 2013, MARS2 2024, Cochrane PVB review, Flores 2007, EORTC 1205, volume-outcome data); replace generic refs with verified primary sources for mortality rates, AF statistics, CRS-HIPEC outcomes, and pain management claims

2026-03-08T04:06:47Z

Add 15 primary peer-reviewed citations (Sugarbaker 2004, Taioli 2015 meta-analysis, Baratti 2013, MARS2 2024, Cochrane PVB review, Flores 2007, EORTC 1205, volume-outcome data); replace generic refs with verified primary sources for mortality rates, AF statistics, CRS-HIPEC outcomes, and pain management claims

Show changes

MesotheliomaSupport: Remove H1, convert exec summary to lead, add listicle

2026-02-24T06:41:20Z

Remove H1, convert exec summary to lead, add listicle

← Older revision		Revision as of 06:41, 24 February 2026
Line 39:		Line 39:
	\|}		\|}

	~~= Mesothelioma Surgery~~ Recovery~~: What to Expect After~~ P/D, EPP, and ~~CRS~~-~~HIPEC~~ =		'''Recovery from mesothelioma surgery''' represents one of the most critical phases of the treatment journey, varying significantly based on the type of surgical procedure performed, the patient's baseline health, and the extent of disease. The three major mesothelioma surgical procedures — [[Pleurectomy_and_Decortication\|pleurectomy/decortication (P/D)]], '''extrapleural pneumonectomy (EPP)''', and cytoreductive surgery with [[Heated_Chemotherapy_HITHOC_and_HIPEC\|HIPEC]] — each carry distinct recovery trajectories, complication profiles, and long-term rehabilitation needs.<ref name="pmc_complications" /><ref name="dandell_treatment" />

	== ~~Executive Summary =~~=		'''Pleurectomy/decortication''', the lung-sparing approach that has become the preferred surgical option at most high-volume centers, typically requires '''7 to 14 days''' of hospitalization with 1 to 3 days in the intensive care unit, followed by '''4 to 8 weeks''' of home recovery. The most common complication is prolonged air leak from the denuded lung surface, occurring in approximately '''6% of patients'''. Extrapleural pneumonectomy, the more radical procedure involving complete lung removal, requires approximately '''2 weeks''' of hospitalization and '''6 to 8 weeks''' for initial recovery, though full adaptation to single-lung physiology may take 3 to 4 months. '''Atrial fibrillation''' is the most significant cardiac complication after EPP, occurring in '''21–44% of patients'''.<ref name="pmc_pd_vs_epp" /><ref name="pmc_technical_pitfalls" /><ref name="mlc_treatment" />

	~~Recovery from [[Mesothelioma\|~~mesothelioma]] surgery ~~represents one of the most critical phases of the treatment journey~~, ~~varying significantly based on the type of surgical~~ procedure ~~performed~~, ~~the patient~~'~~s baseline health~~, and ~~the extent~~ of ~~disease~~. ~~The three major mesothelioma surgical procedures — [[Pleurectomy_and_Decortication\|pleurectomy~~/decortication (P/D)]], extrapleural pneumonectomy (EPP), and cytoreductive surgery with [[Heated_Chemotherapy_HITHOC_and_HIPEC\|HIPEC]] — each carry distinct recovery trajectories, complication profiles, and long-term rehabilitation needs.<ref name="~~pmc_complications~~" /><ref name="~~dandell_treatment~~" />		For peritoneal mesothelioma patients undergoing cytoreductive surgery with HIPEC, hospital stays range from '''8 to 22 days''' with approximately '''3 months''' required for full recovery, including careful dietary progression as gastrointestinal function returns. Across all procedure types, '''multimodal pain management''' combining epidural analgesia with non-opioid agents and regional nerve blocks has become standard practice, while structured pulmonary rehabilitation programs have demonstrated significant improvements in physical function and quality of life.<ref name="pmc_pain_management" /><ref name="pmc_pulmonary_rehab" /><ref name="mesonet_treatment" />

	~~Pleurectomy~~/~~decortication, the lung-sparing approach that has become the preferred surgical option at most high-volume centers,~~ typically ~~requires~~ 7 to 14 days of ~~hospitalization with 1 to 3~~ days in ~~the intensive care unit, followed by 4~~ to ~~8 weeks of home recovery. The most common complication is prolonged air leak from~~ the denuded lung ~~surface, occurring in~~ approximately 6% ~~of patients~~. ~~Extrapleural pneumonectomy~~, the more radical procedure involving complete lung removal, requires approximately 2 weeks of hospitalization and 6 to 8 weeks for initial recovery, though full adaptation to single-lung physiology may take 3 to 4 months. Atrial fibrillation ~~is the most significant cardiac complication~~ after EPP~~, occurring~~ in 21–44% of patients.~~<ref name="pmc_pd_vs_epp"~~ /><ref name="pmc_technical_pitfalls~~" /><ref name="mlc_treatment~~" />		'''Mesothelioma surgery recovery at a glance:'''
			* '''ICU stay after P/D''' — patients typically spend 1–3 days in intensive care with continuous monitoring of vital signs and chest tube output<ref name="pmc_complications" />
	~~For peritoneal mesothelioma patients undergoing cytoreductive surgery with~~ HIPEC, hospital stays ~~range from 8 to 22~~ days with approximately 3 months ~~required~~ for full recovery, including ~~careful~~ dietary progression as gastrointestinal function returns. Across all procedure types, multimodal pain management combining epidural analgesia with non-opioid agents and regional nerve blocks has become standard practice, while structured ~~pulmonary~~ rehabilitation programs ~~have demonstrated significant improvements in physical function~~ and ~~quality of life.~~<ref name="~~pmc_pain_management~~" /><ref name="~~pmc_pulmonary_rehab~~" /><ref name="~~mesonet_treatment~~" />		* '''P/D hospital stay''' — total hospitalization ranges from 7 to 14 days, with most experienced surgeons citing an average of 10–12 days<ref name="pmc_complications" />
			* '''Chest tube duration''' — tubes remain in place for 10–12 days after P/D to drain fluid and help the denuded lung re-expand<ref name="shc_complications" />
			* '''EPP perioperative mortality''' — approximately 4.5% compared to 1.7% for lung-sparing P/D, driving the shift toward P/D at major centers<ref name="pmc_pd_vs_epp" />
			* '''Atrial fibrillation after EPP''' — occurs in 21–44% of EPP patients versus only 7.4% of P/D patients, requiring continuous cardiac monitoring<ref name="pmc_technical_pitfalls" />
			* '''CRS-HIPEC recovery''' — hospital stays of 8–22 days with approximately 3 months for full recovery, including staged dietary progression<ref name="asco_hipec_outcomes" />
			* '''Pulmonary rehab adherence''' — structured rehabilitation programs achieve 93% adherence at 1 month and 83% at 6 months post-P/D<ref name="pmc_pulmonary_rehab" />
			* '''Prolonged air leak rate''' — the most common P/D complication at approximately 6%, requiring extended chest tube management<ref name="shc_complications" />
			* '''Activity restrictions''' — patients are instructed to avoid lifting more than 10 pounds for 6–8 weeks and walk at least 20 minutes daily<ref name="mlc_treatment" />
			* '''Adjuvant chemotherapy timing''' — cisplatin/pemetrexed typically begins 4–8 weeks after surgery once adequate recovery is achieved<ref name="pmc_pain_management" />

	{\| class="wikitable" style="width:100%; border:2px solid #1a5276; margin:1em 0;"		{\| class="wikitable" style="width:100%; border:2px solid #1a5276; margin:1em 0;"

MesotheliomaSupport: Internal linking: added 1 wiki links

2026-02-20T21:02:18Z

Internal linking: added 1 wiki links

← Older revision		Revision as of 21:02, 20 February 2026
Line 43:		Line 43:
	== Executive Summary ==		== Executive Summary ==

	Recovery from mesothelioma surgery represents one of the most critical phases of the treatment journey, varying significantly based on the type of surgical procedure performed, the patient's baseline health, and the extent of disease. The three major mesothelioma surgical procedures — [[Pleurectomy_and_Decortication\|pleurectomy/decortication (P/D)]], extrapleural pneumonectomy (EPP), and cytoreductive surgery with [[Heated_Chemotherapy_HITHOC_and_HIPEC\|HIPEC]] — each carry distinct recovery trajectories, complication profiles, and long-term rehabilitation needs.<ref name="pmc_complications" /><ref name="dandell_treatment" />		Recovery from [[Mesothelioma\|mesothelioma]] surgery represents one of the most critical phases of the treatment journey, varying significantly based on the type of surgical procedure performed, the patient's baseline health, and the extent of disease. The three major mesothelioma surgical procedures — [[Pleurectomy_and_Decortication\|pleurectomy/decortication (P/D)]], extrapleural pneumonectomy (EPP), and cytoreductive surgery with [[Heated_Chemotherapy_HITHOC_and_HIPEC\|HIPEC]] — each carry distinct recovery trajectories, complication profiles, and long-term rehabilitation needs.<ref name="pmc_complications" /><ref name="dandell_treatment" />

	Pleurectomy/decortication, the lung-sparing approach that has become the preferred surgical option at most high-volume centers, typically requires 7 to 14 days of hospitalization with 1 to 3 days in the intensive care unit, followed by 4 to 8 weeks of home recovery. The most common complication is prolonged air leak from the denuded lung surface, occurring in approximately 6% of patients. Extrapleural pneumonectomy, the more radical procedure involving complete lung removal, requires approximately 2 weeks of hospitalization and 6 to 8 weeks for initial recovery, though full adaptation to single-lung physiology may take 3 to 4 months. Atrial fibrillation is the most significant cardiac complication after EPP, occurring in 21–44% of patients.<ref name="pmc_pd_vs_epp" /><ref name="pmc_technical_pitfalls" /><ref name="mlc_treatment" />		Pleurectomy/decortication, the lung-sparing approach that has become the preferred surgical option at most high-volume centers, typically requires 7 to 14 days of hospitalization with 1 to 3 days in the intensive care unit, followed by 4 to 8 weeks of home recovery. The most common complication is prolonged air leak from the denuded lung surface, occurring in approximately 6% of patients. Extrapleural pneumonectomy, the more radical procedure involving complete lung removal, requires approximately 2 weeks of hospitalization and 6 to 8 weeks for initial recovery, though full adaptation to single-lung physiology may take 3 to 4 months. Atrial fibrillation is the most significant cardiac complication after EPP, occurring in 21–44% of patients.<ref name="pmc_pd_vs_epp" /><ref name="pmc_technical_pitfalls" /><ref name="mlc_treatment" />

MesotheliomaSupport: Create comprehensive surgery recovery page: P/D, EPP, CRS-HIPEC timelines, complications, pain management, rehabilitation

2026-02-20T04:53:56Z

Create comprehensive surgery recovery page: P/D, EPP, CRS-HIPEC timelines, complications, pain management, rehabilitation

Show changes